|
Market Closed -
Euronext Paris
11:55:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 4.060 EUR | -1.22% |
|
+1.50% | +2.92% |
| 09-03 | Treatment period completed for Inventiva's NATiV3 study |  |
| 09-02 | Inventiva Says All Patients Completed 72-Week Treatment Period in Phase 3 Liver Disease Study | MT |
| Market Cap | 959M 1.11B 903M 824M 1.54B 105B 1.55B 10.67B 4.14B 54B 4.19B 4.09B 174B | P/E 2026 * |
-5.76x | P/E 2027 * | -5.19x |
|---|---|---|---|---|---|
| Enterprise Value | 840M 976M 790M 722M 1.35B 92.14B 1.35B 9.34B 3.62B 47.28B 3.66B 3.58B 152B | EV / Sales 2026 * |
113x | EV / Sales 2027 * | 3.59x |
| Free-Float |
89.08% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| IVA | Real-time | |
CBOE
| IVAp | Real-time | |
|
Börse Stuttgart
| 6IV | Delayed | |
|
Xetra
| 6IV | Delayed | |
|
Tradegate
| 6IV | Real-time | |
|
London S.E.
| 0RNK | Delayed | |
|
Boerse Muenchen
| 6IV | Real-time | |
|
OTC Markets
| IVEVF | Delayed | |
|
Deutsche Boerse AG
| 6IV | Delayed | |
|
CBOE
| 0RNK | Real-time |
Last Transcript : Inventiva
| 1 day | -1.22% | ||
| 1 week | +1.50% | ||
| Current month | +0.25% | ||
| 1 month | +4.77% | ||
| 3 months | +16.00% | ||
| 6 months | -23.54% | ||
| Current year | +2.92% |
| 1 week | 3.84 |  | 4.39 |
| 1 month | 3.84 | | 4.39 |
| Current year | 2.88 | | 6.2 |
| 1 year | 2.88 | | 6.2 |
| 3 years | 1.43 | | 6.2 |
| 5 years | 1.43 | | 13.18 |
| 10 years | 1.43 | | 16.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Obenshain
CEO | Chief Executive Officer | 53 | 2025-09-30 |
| Director of Finance/CFO | 59 | 2026-04-21 | |
| Chief Operating Officer | - | 2026-08-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Annick Schwebig
BRD | Director/Board Member | 76 | 2017-01-31 |
| Director/Board Member | 63 | 2019-05-26 | |
G. Turenne
BRD | Director/Board Member | 52 | 2024-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/10/26 | Others | Executive/Senior Manager | 50,000 | 0.0262% | ||
| 1/10/26 | Others | General Counsel | 25,000 | 0.0131% | ||
| 1/10/26 | Others | Head of Human Resources | 25,000 | 0.0131% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.22% | +1.50% | -9.07% | +12.78% | 1.11B | |
| -1.79% | -2.27% | +43.23% | +88.96% | 67.98B | |
| -2.06% | -0.18% | +39.67% | +86.44% | 64.94B | |
| -0.31% | +6.54% | -12.96% | +378.92% | 27.58B | |
| +0.86% | +1.65% | -7.74% | -14.95% | 26.06B | |
| -3.00% | -2.90% | +33.13% | +12.54% | 25.74B | |
| -1.46% | +0.42% | +23.61% | -18.61% | 20.09B | |
| -2.96% | -15.21% | +216.20% | +368.10% | 17.16B | |
| -1.49% | -4.88% | -6.60% | +531.89% | 14.92B | |
| -0.20% | +8.37% | +55.78% | +164.98% | 14.62B | |
| Average | -1.36% | +0.38% | +37.52% | +161.10% | 28.02B | |
| Weighted average by Cap. | -1.52% | +0.18% | +38.19% | +136.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.41M 8.61M 6.97M 6.37M 11.91M 813M 11.95M 82.37M 31.97M 417M 32.33M 31.63M 1.34B | 109M 127M 103M 93.86M 176M 11.98B 176M 1.21B 471M 6.15B 477M 466M 19.81B |
| Net income | -152M -176M -143M -130M -244M -16.64B -245M -1.69B -654M -8.54B -662M -647M -27.51B | -104M -121M -97.93M -89.46M -167M -11.42B -168M -1.16B -449M -5.86B -454M -444M -18.88B |
| Net Debt | -120M -139M -112M -103M -192M -13.11B -193M -1.33B -516M -6.73B -522M -510M -21.67B | -567M -659M -533M -487M -911M -62.19B -914M -6.3B -2.45B -31.91B -2.47B -2.42B -103B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | €4.060 | -1.22% | 816,723 |
| 26-09-03 | €4.110 | +0.61% | 600,056 |
| 26-09-02 | €4.085 | +0.37% | 362,971 |
| 26-09-01 | €4.070 | +0.49% | 572,187 |
| 26-08-31 | €4.050 | +1.25% | 1,064,648 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IVA Stock
Select your edition
All financial news and data tailored to specific country editions
